Concepedia

Andy Chi

AC

Statistics

Publications

2

Citations

751

H-Index

2

Active since

2015

Affiliations

Takeda (United States)(Current)

Andy Chi is an author at Takeda (United States) specializing in medicine, oncology, and cancer therapeutics.

Top concepts

MedicineOncologyCell TherapyEpidemiologyHealth PolicyImmunotherapyPublic HealthCancer TherapyPatient SafetyTransplantation

Publications per year

2015–2020

2

Publications

2

Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial

Craig H. Moskowitz, Auayporn Nademanee, Tamás Masszi et al. · The Lancet · 2015 · 726 citations · Full text

Lymphoid Neoplasia, Cell Therapy, Transplantation +10

Practical considerations of utilizing propensity score methods in clinical development using real-world and historical data

Qing Li, Jianchang Lin, Andy Chi et al. · Contemporary Clinical Trials · 2020 · 25 citations

Health Policy, Real World Evidence, Practical Considerations +12

1–2 of 2